EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: subject:"Data Exclusivity"
Narrow search

Narrow search

Year of publication
Subject
All
Pharmaceuticals 14 TRIPS 14 Access to Medicines 12 Data Exclusivity 12 Intellectual Property 12 Patent 12 Health 11 Innovation 10 Affordable Medicines 8 Arzneimittel 8 Flexibilities 8 Immaterialgüterrechte 7 Intellectual property rights 7 Welt 7 World 7 Compulsory Licenses 6 Evergreening 6 Least Developed Countries (LDCs) 6 Research and Development (R&D) 6 World Health Organization (WHO) 6 Patent law 5 Patentrecht 5 Pharmaceutical industry 5 Pharmacology 5 Pharmaindustrie 5 Pharmakologie 5 data exclusivity 5 Biologics 4 COVID-19 4 Diagnostics 4 Doha Declaration on the TRIPS Agreement and Public Health 4 Generic Medicines 4 Global Health 4 Government Use 4 Handelsabkommen 4 Intellectual Property (IP) Enforcement 4 Patent Term 4 Public Health 4 Trade agreement 4 Vaccines 4
more ... less ...
Online availability
All
Free 14 Undetermined 4
Type of publication
All
Book / Working Paper 15 Article 4
Type of publication (narrower categories)
All
Working Paper 8 Arbeitspapier 7 Graue Literatur 7 Non-commercial literature 7 Research Report 6 Article in journal 3 Aufsatz in Zeitschrift 3 Hochschulschrift 1
more ... less ...
Language
All
English 16 Spanish 2 Undetermined 1
Author
All
Correa, Carlos María 4 Acquah, Daniel Opoku 2 Borges, Luciana Correira 2 Boru, Zeleke Temesgen 2 Falcão, Daniela de Santana 2 Lima, Gustavo Soares Felix 2 Paranhos, Julia 2 Syam, Nirmalya 2 Torres, Ricardo Lobato 2 Wagner, Stefan 2 Dureja, Harish 1 Gaessler, Fabian 1 Gäßler, Fabian 1 Menezes, Henrique Zeferino de 1 Palmedo, Michael 1 Prajapati, Vandana 1 Sauer, Corinne 1 Sauer, Robert 1 Shaikh, Owais H. 1 Tripathy, Swagat 1 Yin, Qian 1 de Menezes, Henrique Zeferino 1
more ... less ...
Institution
All
Ludwig-Maximilians-Universität München 1 Springer-Verlag GmbH 1
Published in...
All
Research Paper 6 Research paper 6 Discussion Paper 1 Discussion paper 1 Journal of globalization and development 1 Journal of medical marketing : device, diagnostic and pharmaceutical marketing 1 Journal of world trade : law, economic policy, public policy 1 Munich studies on innovation and competition 1 The Journal of Technology Transfer 1
more ... less ...
Source
All
ECONIS (ZBW) 11 EconStor 7 RePEc 1
Showing 11 - 19 of 19
Cover Image
Non-violation and situation complaints under the TRIPS Agreement : implications for developing countries
Syam, Nirmalya - 2020
Persistent link: https://www.econbiz.de/10012433958
Saved in:
Cover Image
Guide for the granting of compulsory licenses and government use of pharmaceutical patents
Correa, Carlos María - 2020
Persistent link: https://www.econbiz.de/10012433977
Saved in:
Cover Image
Guía para la concesión de licencias obligatorias y uso gubernamental de patentes farmacéuticas
Correa, Carlos María - 2020
Persistent link: https://www.econbiz.de/10012433982
Saved in:
Cover Image
The comprehensive and progressive agreement for the trans-pacific partnership : data exclusivity and access to biologics
Boru, Zeleke Temesgen - 2020
Persistent link: https://www.econbiz.de/10012433988
Saved in:
Cover Image
Patents, data exclusivity, and the development of new drugs
Gaessler, Fabian; Wagner, Stefan - 2019
invention (through patents) and the clinical trials data submitted for market approval (through data exclusivity). Patent … invalidation during drug development renders data exclusivity the sole source of protection and shifts the period of market …
Persistent link: https://www.econbiz.de/10012141882
Saved in:
Cover Image
Patents, data exclusivity, and the development of new drugs
Gäßler, Fabian; Wagner, Stefan - 2019
invention (through patents) and the clinical trials data submitted for market approval (through data exclusivity). Patent … invalidation during drug development renders data exclusivity the sole source of protection and shifts the period of market …
Persistent link: https://www.econbiz.de/10012064786
Saved in:
Cover Image
Access to medicine versus test data exclusivity : safeguarding flexibilities under international law
Shaikh, Owais H. - 2016
Introduction -- Test Data Exclusivity: Raison d'être -- Test Data Exclusivity and Art 39(3) TRIPS -- Test Data … Exclusivity in the US and the EU -- Index of Data Exclusivity and Access (IDEAS) -- Free Trade Agreements -- Index of Data … Exclusivity and Access (IDEAS) -- National Laws -- Test Data Exclusivity in FTAs and Access to Originator Pharmaceuticals …
Persistent link: https://www.econbiz.de/10013447192
Saved in:
Cover Image
Product lifecycle management through patents and regulatory strategies
Prajapati, Vandana; Tripathy, Swagat; Dureja, Harish - In: Journal of medical marketing : device, diagnostic and … 13 (2013) 3, pp. 171-180
Persistent link: https://www.econbiz.de/10009791595
Saved in:
Cover Image
Is it possible to have cheaper drugs and preserve the incentive to innovate? The benefits of privatizing the drug approval process
Sauer, Corinne; Sauer, Robert - In: The Journal of Technology Transfer 32 (2007) 5, pp. 509-524
Persistent link: https://www.econbiz.de/10005810023
Saved in:
  • First
  • Prev
  • 1
  • 2
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...